SA BREAST CANCER SYMPOSIUM
San Antonio, TX - SABCS 2012 San Antonio Breast Cancer Symposium: D Cameron discusses S6-5. Primary results of BEATRICE, a randomized phase III trial evaluating adjuvant bevacizumab-containing therapy in triple-negative breast cancer during the General Session 6 at the 2012 San Antonio Breast Cancer Symposium here today, Saturday December 8, 2012. Over 9,000 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention. Date: Saturday December 8, 2012 Photo by © SABCS/Bahram Mark Sobhani 2012 Technical Questions: email@example.com; Phone: 612-226-5154.